More
    Guided Solutions - Connecting Talent With Innovation/div>

    Blue Arbor wins FDA breakthrough nod for neuromuscular interface

    Blue Arbor Technologies announced today that it received FDA breakthrough device designation for its Restore neuromuscular interface system. The FDA also accepted the system into...

    4D Path secures FDA Breakthrough Designation for Q-plasia OncoReader Breast

    4D Path has secured the US Food and Drug Administration (FDA) Breakthrough Device Designation for Q-plasia OncoReader Breast, its first software-as-a-medical-device solution. The new 4D...

    Front Line Medical wins CE mark for COBRA-OS device

    Front Line Medical Technologies today announced it received CE mark approval for its COBRA-OS device. The CE mark gives EU medical providers access to...

    FDA clears Epitel remote monitoring tech, AI detection platform

    Epitel announced received FDA 510(k) clearance for two new patient-focused brain health offerings. The FDA cleared the Remi remote EEG monitoring system for ambulatory...

    Pantheon meets with FDA to discuss PMA submission for corneal implants

    Pantheon Vision has completed two pre-submission meetings with the US Food and Drug Administration (FDA) as the company looks to advance its corneal implants...

    FDA approves Lumicell’s breast cancer visualization system

    Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal. According to the company, the LumiSystem allows surgeons...

    FDA approves XStim spine fusion stimulator

    Xstim announced today that it received premarket approval from the FDA for its Xstim spine fusion stimulator device.Irving, Texas-based Xstim designed its capacitively coupled...

    Adherium’s Smartinhaler gains clearance for use with AstraZeneca devices

    Adherium has obtained US Food and Drug Administration (FDA) clearance for the use of its Hailie Smartinhaler with AstraZeneca’s Airsupra and Breztri inhalation devices. This...

    IceCure submits final breast cancer cryoablation data to FDA

    IceCure Medical announced it submitted final data to the FDA requesting marketing authorization for its ProSense system. Caesarea, Israel-based IceCure designed ProSense to deliver...

    Latest articles